ASCO GU 2026 Updates | Genitourinary Cancer Clinical Trials & Expert Discussion | OncoWisdom

*ASCO GU 2026 Updates | Genitourinary Cancer Research & Clinical Trials* What are the latest developments in genitourinary cancer treatment from ASCO GU 2026? In this OncoWisdom Circle webinar, oncology experts review important clinical trial findings presented at the ASCO Genitourinary Cancers Symposium 2026, focusing on bladder cancer, kidney cancer, emerging treatment strategies and evidence-based clinical decision-making. *Webinar Topic:* How to Make Sense of Data from ASCO GU 2026 *Program Director:* Dr. Amol Akhade Medical Oncologist, Mumbai, India *Featured Speaker:* Dr. Neelam Singh Assistant Professor, Medical Oncology AIIMS Bhubaneswar, India *Key Topics Covered:* ASCO GU 2026 research updates Muscle-invasive bladder cancer (MIBC) Metastatic urothelial carcinoma Kidney cancer and renal cell carcinoma (RCC) Neoadjuvant and adjuvant cancer treatments Immunotherapy and targeted therapies Treatment sequencing and clinical trial interpretation Expert discussions on emerging oncology evidence *Clinical Trials Discussed Include:* KEYNOTE-B15 / EV-304 LITESPARK-022 KEYNOTE-905 / EV-303 Other emerging genitourinary oncology research *About OncoWisdom Circle* OncoWisdom Circle is a knowledge-sharing initiative dedicated to oncology education, scientific research and expert-led clinical discussions. Subscribe to @OncoWisdomOfficial for more oncology webinars, clinical trial updates and medical education. *Medical Disclaimer:* This webinar is intended for educational and professional discussion only. It does not replace individualized medical advice. Clinical treatment decisions should be made by qualified healthcare professionals using current evidence and appropriate clinical judgment. #ASCOGU2026 #GenitourinaryCancer #BladderCancer #KidneyCancer #OncoWisdom